Tower Research Capital LLC (Trc) Cabaletta Bio, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,367 shares of CABA stock, worth $10,087. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,367
Previous 51,036
91.44%
Holding current value
$10,087
Previous $77,000
87.01%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CABA
# of Institutions
83Shares Held
72.8MCall Options Held
1.1MPut Options Held
14.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$22.4 Million7.24% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$20.4 Million0.03% of portfolio
-
Jennison Associates LLC8.5MShares$19.6 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.36MShares$19.3 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$11.6 Million1.86% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $67M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...